The global multiomics market, which integrates multiple molecular profiling methods, is projected to grow from $3.18 billion in 2026 to $5.70 billion by 2031, a 12.3% compound annual growth rate. Demand is being supported by precision medicine, oncology, drug discovery and translational research, alongside advances in single-cell analysis, spatial omics, next-generation sequencing (NGS), mass spectrometry, artificial intelligence, machine learning and cloud bioinformatics. Products held the largest offering share in 2025, while services are forecast to grow fastest through 2031. Single-cell omics led the market by method in 2025, and spatial omics is expected to expand fastest. Asia Pacific is projected to record the highest CAGR, supported by research investment, government funding and expanding biotechnology capabilities.